• [2021]
• [2020]
• [2019]
• [2018]
• [2017]
• [2016]
• [2015]
• [2014]
• [2013]
• [2012]
• [2011]
• [2010]
• [2009]
• [2008]
• [2007]
• [2006]
• [2005]
• [2004]
• [2003]
• [2002]
• [2001]
• [2000]
• [1999]
• [1998]
• [1997]
• [1996]
• [1995]
• [1994]
• [1993]
• [1992]
• [1991]
• [1990]
• [1989]
• [1988]
• [1987]
• [1986]

Hayakawa, K., Tateda, K., Fuse, E. T., Matsumoto, T., Akasaka, Y., Ishii, T., Nakayama, T., Taniguchi, M., Kaku, M., Standiford, T. J., and Yamaguchi, K.: Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: another aspect of NKT cells for modulation of host responses. J. Med. Microbiol. 57:1340-1348 (2008). (2.091)

Gilliver, S. C., Ruckshanthi, J. P., Hardman, M. J., Nakayama, T., and Ashcroft, G. S.: Sex dimorphism in wound healing: the roles of sex steroids and macrophage migration inhibitory factor. Endocrinology 149:5747-5757 (2008). (5.045)

Terashima, A., Watarai, H., Inoue, S., Sekine, E., Nakagawa, R., Hase, K., Iwamura, C., Nakajima, H., Nakayama, T., and Taniguchi, M.: A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205:2727-2733 (2008). (15.612)

Shinnakasu, R., Yamashita, M., Kuwahara, M., Hosokawa, H., Hasegawa, A., Motohashi, S., and Nakayama, T.: Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J. Biol. Chem. 283:28216-28225 (2008). (5.581)

Kawamura, T., Murakami, K., Bujo, H., Unoki, H., Jiang, M., Nakayama, T., and Saito, Y.: Matrix metalloproteinase-3 enhances the free fatty acids-induced VEGF expression in adipocytes through toll-like receptor 2. Exp. Biol. Med. 233:1213-1221 (2008). (1.979)

Hossain, M. B., Hosokawa, H., Hasegawa, A., Watarai, H., Taniguchi, M., Yamashita, M., and Nakayama, T.: Lymphoid enhancer factor (LEF1) interacts with GATA3 and controls its function in T helper type 2 cells. Immunology 125:377-386 (2008). (3.398)

Hirahara, K., Yamashita, M., Iwamura, C., Shinoda, K., Hasegawa, A., Yoshizawa, H., Koseki, H., Gejyo, F., and Nakayama, T.: Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J. Allergy Clin. Immunol. 122:512-520.e11 (2008). (8.115)

Suto, A., Kashiwakuma, D., Kagami, S., Hirose, K., Watanabe, N., Yokote, K., Saito, Y., Nakayama, T., Grusby, J. M., Iwamoto, I., and Nakajima, H.: Development and characterization of IL-21-producing CD4⁺ T cells. J. Exp. Med. 205:1369-1379 (2008). (15.612)

Ito, T., Hasegawa, A., Hosokawa, H., Yamashita, M., Motohashi, S., Naka, T., Okamoto, Y., Fujita, Y., Ishii, Y., Taniguchi, M., Yano, I., and Nakayama, T.: Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172. Int. Immunol. 20:849-860 (2008). (3.29)

Nakayama, T., and Yamashita, M.: Initiation and maintenance of Th2 cell identity. Truncated title: Regulation of Th2 responses. Curr. Opin. Immunol. 20:265-271 (2008). (9.325)

Iwamura, C., and Nakayama, T.: Toll-like receptors in the respiratory system: their roles in inflammation. Curr. Allergy Asthma Rep. 8:7-13 (2008).

Ito, H., Ando, K., Ishikawa, T., Nakayama, T., Taniguchi, M., Saito, K., Imawari, M., Moriwaki, H., Yokochi, T., Kakumu, S., and Seishima, M.: Role of Vα14⁺ NKT cells in the development of hepatitis B virus specific CTL: Activation of Vα14⁺ NKT cells promote the breakage of CTL tolerance. Int. Immunol. 20:869-879 (2008). (3.29)

Hoshino, A., Nagao, T., Nagi, M. N., Ohno, N., Yasuhara, M., Yamamoto, K., Nakayama, T., and Suzuki, K.: MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J. Autoimmun. 31:79-89 (2008). (3.391)

Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnakasu, R., Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A., and Nakayama, T.: Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J. Exp. Med. 205:1109-1120 (2008). (15.612)

Motohashi, S., and Nakayama, T.: Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci. 99:638-645 (2008). (3.165)

Yamashita, M., and Nakayama, T.: Progress in allergy signal research on mast cells: Regulation of allergic airway inflammation through toll-like receptor 4-mediated modification of mast cell function. J. Pharmacol. Sci. 106:332-335 (2008). (2.408)

Funeshima, F. N., Fujino, M., Kimura, H., Takahara, S., Nakayama, T., Ezaki, T., and Li, X.-K.: Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras. Transpl. Immunol. 18:302-306 (2008). (2.093)

Kitajima, M., Abe, T., Miyano, K. N., Taniguchi, M., Nakayama, T., and Takaku, H.: Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol. Ther. 16:261-268 (2008). (5.862)

Uchida, T., Horiguchi, S., Tanaka, Y., Yamamoto, H., Kunii, N., Motohashi, S., Taniguchi, M., Nakayama, T., and Okamoto, Y.: Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol. Immunother. 57:337-345 (2008). (3.728)